In conversation with Fierce Pharma, Anthony Billinger, senior director of Compass Strategy at Veeva Systems, sheds light on the rapidly evolving world of commercial data in life sciences—and why ...

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Veeva Systems (VEEV). Veeva ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Veeva Systems is overvalued, trading at frothy levels despite only ~10% growth, and facing a potential slowdown in 2025; I recommend a sell rating. The company excels in the life sciences vertical ...

As part of the partnership, Flatiron Health will join the Veeva Product Partner Program. Flatiron and Veeva customers utilizing Flatiron Clinical Pipe™ will benefit from accelerated deployment ...

The latest trading session saw Veeva Systems (VEEV) ending at $222.72, denoting a -0.42% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a loss of 0.17% ...

Veeva Systems (VEEV) closed the latest trading day at $214.74, indicating a +0.5% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 0.23%.

Ohio has an opportunity to help lead the way to fix the problem. As the founder and CEO of Veeva, a cloud software company made possible by California’s ban on non-compete agreements ...